Glaucoma News

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy, to strengthen its clinical-stage pipeline, according to a press release.

Stand-alone canaloplasty and trabeculotomy with the Omni surgical system showed positive real-world outcomes in reducing IOP and medication use, according to a study published in American Journal of Ophthalmology.

NEW YORK — In this presentation from OSN New York, Thomas W. Samuelson, MD, of Minnesota Eye Consultants, uses surgical footage to demonstrate implantation of the Xen gel stent for the treatment of glaucoma.

NEW YORK — In this presentation from OSN New York, Manjool M. Shah, MD, discusses why stand-alone canal-based MIGS is an alternative to topical medications for glaucoma treatment.

NEW YORK — In this presentation from OSN New York, Nathan M. Radcliffe, MD, shares pearls for effective use of the Durysta implant for treating glaucoma.

Healio spoke with Nathan M. Radcliffe, MD, about disparities that exist in glaucoma care.

Healio spoke with Nathan M. Radcliffe, MD, about the best practices for monitoring glaucoma progression.

Healio spoke with Nathan M. Radcliffe, MD, about the evolution of glaucoma care.

Healio spoke with Nathan M. Radcliffe, MD, about exciting new advancements in the treatment of glaucoma.